Media OutReach
CG Capital, the Leader in Branded Residences in Thailand, Marks Milestone Success for InterContinental Residences Bangkok Asoke Amid Global Economic Uncertainty
Reaffirming Thailand’s status as a world destination for the luxury residences market
Mr. Phoom Chirathivat, Managing Partner and Co-Founder of CG Capital, said that despite a difficult global economic backdrop, marked by slowing markets, geopolitical conflict, and volatility in traditional capital markets, CG Capital sees Thailand’s luxury real estate market moving in the opposite direction. Driving this is a major shift in the behaviour of the world’s wealthiest individuals: a wave of global wealth migration. Data from Henley & Partners shows the number of high-net-worth individuals (HNWIs) relocating globally has surged from 51,000 in 2013 to 142,000 in 2025, a 178% increase over 12 years.
“Global markets are slowing down, but Thailand is holding its position as a world destination. Demand from HNWI buyers, both Thai and international, hasn’t dropped off. If anything, these buyers have become more selective about the assets they choose. That tracks with what we’re seeing from Thailand’s Board of Investment, which has approved Long-Term Resident visas for more than 6,000 wealthy global citizens since 2022. Thailand isn’t just a tourism destination anymore. It’s become a place HNWIs choose for long-term residence and investment,” said Mr. Phoom.
Claiming the Asian Crown: The “Right Brand, Right Partners, Right Product” Strategy
Rising demand for high-end residences has pushed CG Capital’s investment strategy toward branded residences, the fastest-growing segment of the market. Thailand currently holds the largest market share of branded residences in Asia at 23.3% of the region’s USD 26.6 billion total market value, ahead of the Philippines (17.3%) and South Korea (11.6%). CBRE’s Global Branded Residences report ranks Thailand 4th in the world by number of projects, with Bangkok and Phuket sitting among the world’s top 10.
Mr. Phoom Chirathivat added:”The success of InterContinental Residences Bangkok Asoke comes down to understanding global trends. What sets us apart is ‘Right Brand, Right Partners, Right Product,’ paired with Bangkok’s best location, Sukhumvit. We’re not chasing a trend. We’re reading the market and building on the long-term confidence we have in this country.”
From Private Equity DNA to World-Class Product Development
What sets CG Capital apart, as the largest private equity fund manager in Thailand’s real estate and hospitality sector, is the way it applies institutional investment thinking to every part of development. Long-term asset value gets weighed through two lenses at once: capital appreciation and living experience.
CG Capital’s Next Steps and the Official Sales Gallery Launch
Looking ahead, Mr. Phoom said CG Capital will keep pursuing new investment opportunities in the hospitality segment, setting new standards for Thailand’s real estate industry. “Reservations above 60% so far are a clear vote of confidence in CG Capital. Now that the sales gallery is open to the public, we’re confident the design and craftsmanship on display will help the project move quickly toward its sales target, further cementing CG Capital’s position as Thailand’s leading branded residences developer,” he said.
InterContinental Residences Bangkok Asoke welcomes visitors to view show units at the sales gallery from 4–5 July onward. Interested parties may schedule an exclusive private appointment via https://residencesasoke.com/
or Tel: 092-989-2616
Expanding the Reach: Bringing the Project to International Buyers
Alongside the sales gallery opening in Bangkok, CG Capital continues to take InterContinental Residences Bangkok Asoke directly to international buyers. The project will next be featured at “Thailand: A New Chapter Begins,” an exclusive showcase hosted by CBRE Thailand in collaboration with Taiwan Sotheby’s International Realty in Taipei on 3 – 4 July 2026, from 1:30 p.m. – 5:00 p.m. at W Taipei (Strategy Room 1).
Taiwan is a market CG Capital sees as a promising source of long-term residence demand. According to CBRE Thailand and Real Estate Information Center (REIC), Taiwanese buyers now rank as the fourth-largest group of foreign buyers in Thai property market, with transaction value growing an average of 27% a year between 2023 and 2025. Thailand’s appeal to this group comes down to geographic proximity, competitive entry pricing, and a lifestyle suited to long-stay living.
For CG Capital, the event is also a chance to read first-hand how Taiwanese HNWIs are thinking about long-term residence and investment in Thailand. Interested parties in Taiwan may get in touch, please contact Taiwan Sotheby’s International Realty 0800.887.288 (Taiwan) or CBRE Thailand +66(0) 81 742 6624 (Thailand).
Hashtag: #CGCapital #InterContinentalResidencesBangkokAsoke
https://centralgroupcapital.com/
https://www.facebook.com/Centralgroupcapital/
The issuer is solely responsible for the content of this announcement.
About CG Capital
CG Capital Advisory Limited manages private equity investments for blue-chip domestic and international institutional and UHNW investors with an inaugural fund size of THB 10 billion, investing primarily in Thailand’s hospitality, tourism, and real estate sectors through greenfield, brownfield, and turnaround strategies. Its diversified portfolio includes hotels, branded residences, condominiums, amusement and water parks, and mixed-use developments, focusing on Thailand’s leading travel destinations such as Bangkok, Phuket, Koh Samui, and Pattaya.
Led by Mr. Phoom Chirathivat, Managing Partner and Co-Founder of CG Capital, the firm combines deep expertise in investment and hospitality with a strong conviction in Thailand’s tourism potential—particularly within the luxury and lifestyle segments.
Legal disclaimer
Sixteen Residences Limited, being the current owner and developer of InterContinental Residences Bangkok Asoke, is solely responsible for the development, marketing, and sale of the Units. The Units are not owned, developed or sold by InterContinental Hotels Group PLC or its affiliates (collectively “IHG”). There exists no joint venture, partnership, ownership or similar relationship between Sixteen Residences Limited and IHG. IHG is not responsible for the content presented in this press release.
Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.
ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.
In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.
Acquisitions Support Service Network Expansion
ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.
In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.
By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.
Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.
The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.
Hashtag: #ZenaTech
The issuer is solely responsible for the content of this announcement.
About ZenaTech
ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.
Media OutReach
A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04
Hashtag: #SPOTMAS
https://spotmas.com.hk/The issuer is solely responsible for the content of this announcement.
Media OutReach
St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys
Overview of the WACE Curriculum at SFMS
SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.
SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.
Academic Outcomes and University Placements
In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.
In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.
Student Journeys and Holistic Development
Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.
Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.
Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.
These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational
https://www.sfms.edu.sg/
https://www.facebook.com/sfms.singapore
https://www.instagram.com/sfms_sg/
https://www.youtube.com/channel/UC_bb9hcNhAk7WgYBE_FI61A/featured
The issuer is solely responsible for the content of this announcement.
About St Francis Methodist School International
Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.
